1213 studies found for:    "Depressive Disorder" [DISEASE] | "Depressive Disorder, Major"
Show Display Options
Rank Status Study
21 Completed An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Radafaxine
22 Completed A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder
Conditions: Insomnia;   Depressive Disorder, Major
Interventions: Drug: Eszopiclone;   Other: Placebo
23 Completed Efficacy and Safety Study of Lu AA21004 for Treatment of Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Lu AA21004;   Drug: Placebo
24 Completed A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: GSK561679;   Other: Placebo
25 Unknown  Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
Conditions: Psychotic Disorders;   Depressive Disorder;   Depressive Disorder, Major
Intervention:
26 Completed Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
Conditions: Depressive Disorder, Major;   Metabolic Syndrome X
Intervention: Drug: Pioglitazone
27 Completed An Eight-Week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: saredutant (SR48968);   Drug: paroxetine;   Drug: placebo
28 Completed Safety and Efficacy Study of Lu AA21004 in Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: LuAA21004;   Drug: Placebo
29 Completed Efficacy and Safety Study of Lu AA21004 in Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Lu AA21004;   Drug: Placebo
30 Completed Safety and Efficacy of Lu AA21004 in Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Lu AA21004;   Drug: Duloxetine;   Drug: Placebo
31 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release (DVS SR);   Drug: Placebo;   Drug: Duloxetine 60 mg/day
32 Completed An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
Condition: Depressive Disorder, Major
Intervention: Drug: Escitalopram
33 Completed A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
Condition: Depressive Disorder, Major
Intervention: Drug: Mifepristone
34 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: desvenlafaxine succinate sustained release;   Genetic: Genotyping
35 Withdrawn The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Agomelatine;   Drug: Fluoxentine
36 Completed Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Quetiapine (Seroquel) XR
37 Terminated Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: CP-316,311;   Drug: Placebo;   Drug: Sertraline
38 Completed An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Radafaxine
39 Terminated A Study of GW856553X For the Treatment of Depression
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW856553X or placebo
40 Completed Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features
Condition: Depressive Disorder, Major
Intervention: Drug: Bupropion extended release

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years